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Abstract
Background The recent development of new neo-adjuvant
treatment regimens associated with a higher success rate of
down-staging has increased the interest of pancreatic surgeons
on the role of extended surgery for patients affected by locally
advanced pancreatic cancer. Pancreatectomy together with re-
section of the portal/superior mesenteric vein is considered
nowadays standard of care for patients affected by pancreatic
cancer. However, the resection of major abdominal arteries is
still debatable. In particular, the short- and long-term results
after resection of the superior mesenteric artery (SMA) remain
controversial and only few cases have been described in liter-
ature. The present paper describes a new, quick, and easy
technique for resection of the SMA.
Clinical case A 71-year-old patient affected by IPMN cancer
with infiltration of the SMA received FOLFIRINOX-based
neo-adjuvant treatment. After 4 months of treatment, the pa-
tient underwent total pancreatectomy with en bloc resection of
the SMA and direct end-to-end anastomosis. The vascular
resection was performed combining a complete Cattell-
Braasch maneuver with local bowel hypothermia in an at-
tempt to avoid graft interposition by facilitating an end-to-
end anastomosis and to reduce the warm ischemia time. The
post-operative course was uneventful and the patient was
discharged 8 days post-operatively.
Keywords Resection of superior mesenteric artery .
Pancreatectomy associated to vascular resection . Pancreas
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Background
At the time of diagnosis, about 30 % of the patients with
pancreatic ductal adenocarcinoma (PDAC) are excluded from
surgical resection due to locally advanced disease [1].
Recently, the International Study Group for Pancreatic
Surgery published a consensus paper in which the resection
of the superior mesenteric/portal vein (SMPV) is considered
standard of care in case of limited tumor encasement [2].
There is much less evidence, however, regarding the value
of the arterial resections in PDAC. In a meta-analysis,
Mollberg and co-workers stated that pancreatectomies with
arterial resections are associated with a poor short- and long-
term outcome [3]. Recent data from literature, however, im-
plies that the short-term outcome of arterial resections per-
formed in expert hands is comparable to that of conventional
pancreatectomies [4]. Other data shows that long-term results
are better for isolated arterial resections only rather than com-
bined arterial-venous ones [1]. The advantageous long-term
outcome probably reflects the fact that a single-artery contact
is an expression of a tumor occurring in an unfavorable loca-
tion rather than a locally advanced tumor growth, involving
multiple vessels. Furthermore, published data shows that, for
patients with the same stage of disease, the long-term progno-
sis is better if they are treated with pancreatectomy with iso-
lated arterial resection compared to palliative chemo (-radio)
therapy.
The recent development of new neo-adjuvant treatment
regimens associated with a higher success rate of down-
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staging [5] has increased the interest of pancreatic surgeons on
the role of extended surgery for patients affected by locally
advanced pancreatic cancer. For this reason, the consensus
paper from the International Study Group for Pancreas
Surgery encourages further investigations of the role of more
extensive surgery after neo-adjuvant treatment. The hepatic
artery and the celiac trunk are the most frequently resected
arteries in pancreatectomy. There are not many cases of supe-
rior mesenteric artery (SMA) resections reported in literature
[3] and there are multiple reasons for this. One reason is prob-
ably that the involvement of the SMA most often reflects a
locally advanced tumor growth involving multiple vessels.
Also, the resection of the SMA is a technically complex op-
eration associated with several intra- and post-operative life-
threatening complications such as bowel ischemia-reperfusion
syndrome and SMA thrombosis. The ischemia-reperfusion
injury is dependent on two major factors: the duration of is-
chemia and the temperature of the organ at stake, in this case
the intestine [6]. During SMA resection, the duration of ische-
mia is variable according to different surgical techniques.
Generally, the most often used technique is graft interposition
from the aorta to the SMA stump in the root of mesentery. This
technique generally requires quite a long ischemia time, con-
sidering that two anastomoses are needed. Alternatively, a
rotation of the splenic artery can be used to rebuild the SMA
continuity. End-to-end anastomoses have also been reported,
but generally only for resection of a small segment of the
SMA [1]. During the clamping time of the SMA, the bowel
is exposed to warm ischemia. This case report describes a new
original technique for resection of the SMA combining the
Cattell-Braasch maneuver and local bowel hypothermia [7],
in order to facilitate an end-to-end SMA anastomosis and to
reduce the bowel metabolism during the cross clamping of the
SMA.
Case report
A 71-year-old male was admitted with obstructive jaundice at
the end of June 2015. A CT scan of the thorax and abdomen
demonstrated a mixed-type IPMN with a 50-mm cystic/solid
lesion in the head of the pancreas associated with a 3-cm long
and more than 50 % circumferential encasement of the SMA
(Fig. 1). No distant metastases were detected. The patient was
discussed at the Karolinska University Hospital’s multidisci-
plinary conference. The tumor was considered not primary
resectable by oncological means and the patient commenced
chemotherapy. He underwent concomitant endoscopic
ultrasound-guided tumor biopsy and bile duct stenting.
Histology showed IPMN cancer. At the end of July, the patient
started neo-adjuvant treatment with FOLFIRINOX [5] that
was completed 4 months later without significant toxicity. A
new CT scan, demonstrated at the multidisciplinary confer-
ence, showed no occurrence of distant metastases and a partial
response with a reduced tumor size, however with remaining
encasement of the SMA (Fig. 2). As the patient had stable
disease, he underwent surgical exploration by a senior pancre-
atic surgeon (MDC) in December 2015. No distant metastases
or ascites were found at the time of surgery. An extended
Kocher maneuver was performed with a total mobilization
Fig. 1 The preoperative CT-scan
shows a 3-cm tumor infiltration of
the superior mesenteric artery.
SMA = superior mesenteric artery.
PV = portal vein
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of the right colon and of the small bowel, e.g., Cattell-Braasch
maneuver [7]. An aorto-caval lymphadenectomy was done
Ben bloc^ with the mobilization of the head of the pancreas.
The origin of the SMA from the aorta was identified and was
tumor-free (Fig. 3). An anterograde artery-first approach was
done [7, 8] and an accessory right hepatic artery (RHA) orig-
inating from SMAwas detected and preserved (Fig. 4). Two
centimeters distal of the origin of the RHA no clear cleavage
plane between the tumor and SMAwas found for a distance
over 2.5 cm with a free margin of the artery distally at the root
of the mesentery (Fig. 5). At this point, the patient was con-
sidered resectable. Considering the extension of the disease in
the entire gland (mixed-type IPMN) [9], as well as trying to
prevent pancreatic leakage in a patient with arterial resection
and reconstruction, a decision to do a total pancreatectomy
was made. After skeletonization of the hepato-duodenal liga-
ment, transection of the jejunum and duodenum 2 cm distally
to the pylorus, a retrograde distal pancreatico-splenectomy
Fig. 2 The post neo-adjuvant CT
scan shows unchanged tumor
encasement of the superior
mesenteric. SMA = superior
mesenteric artery. PV = portal
vein
Fig. 3 After a Cattell-Braasch
maneuver and en bloc aorto-caval
lymphadenectomy, the origin of
the superior mesenteric artery is
identified immediately above the
left renal vein. SMA = superior
mesenteric artery. IVC = inferior
caval vein
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was done and the head of the pancreas dissected from the
superior mesenteric/portal vein in a complete tumor-free
plane. The specimen now remained attached only by the
2.5 cm long contact with the SMA at the level of the unci-
nate process (Fig. 6). Sterile ice in a surgical towel was
placed in the lower sub-mesocolic abdomen in order to re-
duce the warm ischemia effect and after intra-venous injec-
tion of 5000 IU of heparin, the SMA vas clamped proximal-
ly and distally to the tumor. The SMA was resected 1 cm
proximally and distally to the tumor contact, respectively
(for an overall length of about 4 cm), and an end-to-end
anastomosis was done using interrupted suture with 5/0
Prolene® (Fig. 7). The overall clamping time of the SMA
was 12 min. After reperfusion, the surgical towel with sterile
ice was removed and the bowel was inspected to be normal,
without signs of edema. In this patient, an extended lymph-
adenectomy was also performed for technical reasons (i.e.,
preparation of the SMA for resection and reconstruction) and
for staging reasons after the neo-adjuvant treatment (i.e., for
assessment of aorto-caval lymph node status). A trans-
mesocolic hepatico-jejunostomy and an ante-colic duodeno-
jejunostomy were performed and two passive drains were
placed. The patient received extended antibiotic and anti-
mycotic post-operative prophylaxis and 5000 IU of low-
molecular-weight heparin twice a day for 2 weeks. Low dose
aspirin was introduced on day 5 after surgery. A CT-scan
post-operatively showed normal canalization of the SMA
(Fig. 8). The histology confirmed IPMN cancer (pT3N1)
with a post-chemotherapy regression grade 3 (10) and with-
out invasion of the arterial wall. The post-operative course
Fig. 4 During the anterograde
artery-first maneuver, a replaced
right hepatic artery originating
from the SMA is identified and
preserved. SMA = superior
mesenteric artery. IVC = inferior
caval vein. RHA = right hepatic
artery
Fig. 5 At the point of
resectability assessment. The
superior mesenteric artery appears
free from tumor infiltration in the
root of mesentery below the
mesocolon. SMA = superior
mesenteric artery
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was uneventful and the patient was discharged on day 8.
Interestingly, no post-operative diarrhea occurred.
Discussion
The debate on the safety and the oncologic value of arterial
resection during pancreatectomy for pancreatic cancer is still
open. Data from literature is not consistent and generally
comes from small series. The short- and long-term outcomes
of pancreatectomies associated with arterial resections have
not been encouraging [3]. On the other hand, new more
efficient treatments associated with better outcome are now
available for patients with pancreatic cancer [5]. However,
no data is available regarding the long-term outcome of ex-
tended resections in the context of these new and more effi-
cient neo-adjuvant regimens. Preliminary reports, together
with some evidence suggesting that surgery may have a sur-
vival benefit compared to palliation for patients with locally
advanced pancreatic cancer, motivated the scientific interna-
tional community to be more open to extended resection after
adequate medical treatment [2]. New data also shows that the
histological regression is not necessarily reflected by radiolog-
ical CT findings as fibrosis can hardly be differentiated from
Fig. 6 The dissection is
completed. The tumor remains
attached only on the superior
mesenteric artery. The proximal
and distal part of the artery is
prepared to be clamped to
perform an en bloc resection.
SMA = superior mesenteric artery
Fig. 7 After the en bloc removal
of the specimen including a
segment of the superior
mesenteric artery, the vessel is
reconstructed by an end-to-end
anastomosis using interrupted
Prolene 5/0®. SMA = superior
mesenteric artery. IVC = inferior
caval vein. RHA = right hepatic
artery. SMV = superior mesenteric
vein
Langenbecks Arch Surg (2016) 401:1241–1247 1245
vital tumor on a CT scan [10, 11]. Furthermore, histological
arterial invasion has been confirmed in a median of 26 % of
the resected arteries, which illustrates the difficulties of the
preoperative assessment of arterial encasement [3]. For this
reason, and in the case of a radiological tumor regression after
neo-adjuvant treatment, a locally advanced pancreatic cancer
should be resected according to the pretreatment CT-
demonstrated extent of the tumor, including the vessels in-
volved at that time.
For the above reasons, one may predict that vascular resec-
tions during pancreatic surgery will become more frequent in
the future, and thus, technically safe and Beasy^ techniques are
necessary. The Cattell-Braasch maneuver has already been
demonstrated to be safe and useful for the resection of the
superior mesenteric vein (SMV) [7]. The total mobilization
of the bowel together with the duodenum and the head of
the pancreas not only offer a very good exposure and control
of the origin of the SMA but also make the bowel mobile.
Hence, the maneuver facilitates a tension-free vascular anas-
tomosis and almost always omits the necessity for placement
of an interposition graft both for the SMVand SMA, irrespec-
tive of the length of the resected vascular segment. That re-
duces the vessel clamping time with less ischemia and con-
gestion of the bowel, but also avoids the possible complica-
tions related to the graft usage (thrombosis, kinking). This
case shows that the Cattell-Braasch maneuver can safely be
used for the resection of the SMAwith a short clamping time.
In the present case, we added local hypothermia, a concept
used in transplant surgery. Theoretically, this could reduce the
metabolism of the bowel during clamping and the damage
caused by ischemia-reperfusion (e.g., edema of the bowel),
which represents an increased risk for anastomotic failure.
This could be even more beneficial in case of complex simul-
taneous SMV and SMA resections. Even if this was a single
case with short clamping time and no definite conclusions can
be made regarding the significance of the local hypothermia
for the positive outcome of the procedure, we believe that this
technique merits to be reported, since to our knowledge, this
method has never been described before in the context of
resection of the SMA during pancreatectomy.
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